224 related articles for article (PubMed ID: 27268758)
1. Leveraging a Sturge-Weber Gene Discovery: An Agenda for Future Research.
Comi AM; Sahin M; Hammill A; Kaplan EH; Juhász C; North P; Ball KL; Levin AV; Cohen B; Morris J; Lo W; Roach ES;
Pediatr Neurol; 2016 May; 58():12-24. PubMed ID: 27268758
[TBL] [Abstract][Full Text] [Related]
2. Sturge-Weber syndrome.
Comi AM
Handb Clin Neurol; 2015; 132():157-68. PubMed ID: 26564078
[TBL] [Abstract][Full Text] [Related]
3. Updates on Sturge-Weber Syndrome.
Yeom S; Comi AM
Stroke; 2022 Dec; 53(12):3769-3779. PubMed ID: 36263782
[TBL] [Abstract][Full Text] [Related]
4. Consensus Statement for the Management and Treatment of Sturge-Weber Syndrome: Neurology, Neuroimaging, and Ophthalmology Recommendations.
Sabeti S; Ball KL; Bhattacharya SK; Bitrian E; Blieden LS; Brandt JD; Burkhart C; Chugani HT; Falchek SJ; Jain BG; Juhasz C; Loeb JA; Luat A; Pinto A; Segal E; Salvin J; Kelly KM
Pediatr Neurol; 2021 Aug; 121():59-66. PubMed ID: 34153815
[TBL] [Abstract][Full Text] [Related]
5. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.
Shirley MD; Tang H; Gallione CJ; Baugher JD; Frelin LP; Cohen B; North PE; Marchuk DA; Comi AM; Pevsner J
N Engl J Med; 2013 May; 368(21):1971-9. PubMed ID: 23656586
[TBL] [Abstract][Full Text] [Related]
6. The somatic GNAQ mutation c.548G>A (p.R183Q) is consistently found in Sturge-Weber syndrome.
Nakashima M; Miyajima M; Sugano H; Iimura Y; Kato M; Tsurusaki Y; Miyake N; Saitsu H; Arai H; Matsumoto N
J Hum Genet; 2014 Dec; 59(12):691-3. PubMed ID: 25374402
[TBL] [Abstract][Full Text] [Related]
7. Physical and Family History Variables Associated With Neurological and Cognitive Development in Sturge-Weber Syndrome.
Day AM; McCulloch CE; Hammill AM; Juhász C; Lo WD; Pinto AL; Miles DK; Fisher BJ; Ball KL; Wilfong AA; Levin AV; Thau AJ; Comi AM; ; Koenig JI; Lawton MT; Marchuk DA; Moses MA; Freedman SF; Pevsner J
Pediatr Neurol; 2019 Jul; 96():30-36. PubMed ID: 30853154
[TBL] [Abstract][Full Text] [Related]
8. Current Therapeutic Options in Sturge-Weber Syndrome.
Comi A
Semin Pediatr Neurol; 2015 Dec; 22(4):295-301. PubMed ID: 26706016
[TBL] [Abstract][Full Text] [Related]
9. Somatic GNAQ Mutation is Enriched in Brain Endothelial Cells in Sturge-Weber Syndrome.
Huang L; Couto JA; Pinto A; Alexandrescu S; Madsen JR; Greene AK; Sahin M; Bischoff J
Pediatr Neurol; 2017 Feb; 67():59-63. PubMed ID: 27919468
[TBL] [Abstract][Full Text] [Related]
10. Port-wine Birthmarks: Update on Diagnosis, Risk Assessment for Sturge-Weber Syndrome, and Management.
Poliner A; Fernandez Faith E; Blieden L; Kelly KM; Metry D
Pediatr Rev; 2022 Sep; 43(9):507-516. PubMed ID: 36045161
[TBL] [Abstract][Full Text] [Related]
11. GNA11-mutated Sturge-Weber syndrome has distinct neurological and dermatological features.
Dompmartin A; van der Vleuten CJM; Dekeuleneer V; Duprez T; Revencu N; Désir J; Te Loo DMWM; Flucke U; Eijkelenboom A; Schultze Kool L; Vikkula M; Boon L
Eur J Neurol; 2022 Oct; 29(10):3061-3070. PubMed ID: 35715928
[TBL] [Abstract][Full Text] [Related]
12. Fibronectin: characterization of a somatic mutation in Sturge-Weber syndrome (SWS).
Zhou Q; Zheng JW; Yang XJ; Wang YA; Ye WM; Zhu HG; Zhang ZY
Med Hypotheses; 2009 Aug; 73(2):199-200. PubMed ID: 19359105
[TBL] [Abstract][Full Text] [Related]
13. Sturge-Weber syndrome: an update for the pediatrician.
Dingenen E; Segers D; De Maeseneer H; Van Gysel D
World J Pediatr; 2024 Apr; ():. PubMed ID: 38658498
[TBL] [Abstract][Full Text] [Related]
14. Increased fibronectin expression in sturge-weber syndrome fibroblasts and brain tissue.
Comi AM; Hunt P; Vawter MP; Pardo CA; Becker KG; Pevsner J
Pediatr Res; 2003 May; 53(5):762-9. PubMed ID: 12621118
[TBL] [Abstract][Full Text] [Related]
15. Potential biological targets for bioassay development in drug discovery of Sturge-Weber syndrome.
Mohammadipanah F; Salimi F
Chem Biol Drug Des; 2018 Feb; 91(2):359-369. PubMed ID: 28941044
[TBL] [Abstract][Full Text] [Related]
16. Sturge-Weber syndrome: from the past to the present.
Sudarsanam A; Ardern-Holmes SL
Eur J Paediatr Neurol; 2014 May; 18(3):257-66. PubMed ID: 24275166
[TBL] [Abstract][Full Text] [Related]
17. Sturge-Weber Syndrome: A Review.
Higueros E; Roe E; Granell E; Baselga E
Actas Dermosifiliogr; 2017 Jun; 108(5):407-417. PubMed ID: 28126187
[TBL] [Abstract][Full Text] [Related]
18. The Pathogenesis of Port Wine Stain and Sturge Weber Syndrome: Complex Interactions between Genetic Alterations and Aberrant MAPK and PI3K Activation.
Nguyen V; Hochman M; Mihm MC; Nelson JS; Tan W
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067686
[TBL] [Abstract][Full Text] [Related]
19. Presentation, diagnosis, pathophysiology, and treatment of the neurological features of Sturge-Weber syndrome.
Comi AM
Neurologist; 2011 Jul; 17(4):179-84. PubMed ID: 21712663
[TBL] [Abstract][Full Text] [Related]
20. GNAQ mutations drive port wine birthmark-associated Sturge-Weber syndrome: A review of pathobiology, therapies, and current models.
Van Trigt WK; Kelly KM; Hughes CCW
Front Hum Neurosci; 2022; 16():1006027. PubMed ID: 36405075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
